E2OM Stock Overview
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
STRATA Skin Sciences, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.39 |
52 Week High | US$1.03 |
52 Week Low | US$0.27 |
Beta | 1.61 |
1 Month Change | -6.67% |
3 Month Change | -31.83% |
1 Year Change | -54.94% |
3 Year Change | -72.00% |
5 Year Change | -84.86% |
Change since IPO | -99.88% |
Recent News & Updates
Recent updates
Shareholder Returns
E2OM | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | -8.0% | -2.2% | 0.07% |
1Y | -54.9% | 3.4% | 4.9% |
Return vs Industry: E2OM underperformed the German Medical Equipment industry which returned 6.7% over the past year.
Return vs Market: E2OM underperformed the German Market which returned 5% over the past year.
Price Volatility
E2OM volatility | |
---|---|
E2OM Average Weekly Movement | 14.5% |
Medical Equipment Industry Average Movement | 4.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.1% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: E2OM's share price has been volatile over the past 3 months.
Volatility Over Time: E2OM's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1989 | 114 | Dolev Rafaeli | https://www.strataskinsciences.com |
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions.
STRATA Skin Sciences, Inc. Fundamentals Summary
E2OM fundamental statistics | |
---|---|
Market cap | €15.41m |
Earnings (TTM) | -€6.59m |
Revenue (TTM) | €32.29m |
0.5x
P/S Ratio-2.4x
P/E RatioIs E2OM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
E2OM income statement (TTM) | |
---|---|
Revenue | US$35.27m |
Cost of Revenue | US$14.76m |
Gross Profit | US$20.51m |
Other Expenses | US$27.70m |
Earnings | -US$7.20m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Mar 27, 2024
Earnings per share (EPS) | -0.21 |
Gross Margin | 58.14% |
Net Profit Margin | -20.40% |
Debt/Equity Ratio | 92.7% |
How did E2OM perform over the long term?
See historical performance and comparison